New company, VaxLiant, offers innovative vaccine adjuvants  New
company, VaxLiant, offers innovative vaccine adjuvants  Novel
technology and experience streamlining vaccine development make
VaxLiant unique  Vaxliant logoBenchmark Biolabs, Lincoln, Neb.,
and AgriLabs®, St. Joseph, Mo., announced the formation of
VaxLiant TM, a joint venture designed to modernize how vaccines
deliver antigens to prevent disease. VaxLiant offers a portfolio
of ready-to-use and customizable adjuvants, and technical and
marketing expertise, to help streamline the vaccine-development
process. This new company is headquartered at Benchmark Biolabs’
facilities in Lincoln, and will tap into the experience of
employees from both parent companies.  “What this means is that
vaccine companies now have access to several readily available
adjuvants that provide never-seen-before flexibility in
delivering antigens at a competitive price,” says Steve Schram,
VaxLiant co-founder and AgriLabs chief executive officer.
“VaxLiant is also developin